<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01918748</url>
  </required_header>
  <id_info>
    <org_study_id>I-TRAVLE</org_study_id>
    <nct_id>NCT01918748</nct_id>
  </id_info>
  <brief_title>Effect of I-TRAVLE Training on Arm Function in MS and Chronic Stroke Patients</brief_title>
  <official_title>Effect of a Training Regime Featuring the I-TRAVLE System on Arm Function and Skill Performance in Persons With Multiple Sclerosis and Chronic Stroke Patients: a Single Arm Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hasselt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hasselt University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: Approx. 80% of acute stroke patients suffer from acute hemiparesis. Stroke
      patients have not reached their full potential when they are discharged from hospital. It is
      proven that extra training opportunities lead to further improvement. To date, new training
      possibilities, such as robotic techniques for rehabilitation, virtual reality training
      systems and tele-rehabilitation are being developed to aid in the training of stroke
      patients.

      Objective: To obtain preliminary evidence on the efficacy of an individualised, intensive
      6-week technology-assisted training regime, featuring a robotics-based self-adapting arm
      training system (I-TRAVLE) in a virtual context, focussed on improvement of arm function and
      arm skill performance in chronic stroke patients with low to moderate proximal (shoulder/arm)
      muscle strength.

      Study design: single arm prospective cohort study. Study population: 16 stroke patients in
      the chronic phase after their stroke, aged &gt;=18, diagnosed with a central paresis of the arm,
      having low to moderate proximal (shoulder and arm) muscle strength.

      Intervention (if applicable): Haptic feedback of the I-TRAVLE robot either supports or
      challenges the patient to perform movements of the arm, thereby training motor control and
      co-ordination of the affected arm. Also strength and endurance of arm muscle use may be
      trained. The I-TRAVLE based training will last 6 weeks. Each week participants will attend
      training sessions on 3 days, during which they will train 2x 30 minutes, interspaced by at
      least half an hour to avoid (general) fatigue and overuse.

      Main study parameters/endpoints: Baseline measurements will be performed 3x prior to the
      start of the intervention, each interspaced by 1 week to assess baseline stability or any
      fluctuations in baseline values. In these chronic stroke patients spontaneous improvement is
      not expected. Also measurements will be performed at 0 weeks and at 12 weeks post training.
      Primary outcome measures: Wolf Motor Function Test, ABILHAND, and Goal Attainment Scaling.
      Secondary outcome measures are: motricity index, plate tapping task, active range of motion,
      perceived strength and fatigue.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All tests and exercises are pain free, easy to perform, non-intrusive, and not high
      demanding. Subjects will have to undergo an assessment via a movement protocol as well as
      clinical outcome tests. In both cases the type of assessment does not differ from the normal
      assessment at a rehabilitation centre. The training is assisted using a robotic device called
      the Haptic Master (HM). The participant's arm is attached to the HM via a gimbal. The HM has
      a number of safety features to avoid overload on the participant's arm. Any potential risk
      for overload is minimised by a) careful build-up of the training regime; b) regular
      check-ups; and c) checking the participant's status prior to the next training session.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change from baseline Wolf Motor Function Test at 8 weeks and 3 months.</measure>
    <time_frame>Pre (3x baseline) &amp; post intervention (8 weeks), 3 month follow-up</time_frame>
    <description>The Wolf Motor Function Test (WMFT) test contains 15 timed and 2 strength tasks (lifting the weighted limb and grip strength), ordered from simple to complex, administered sequentially to each upper extremity and controlling for patient positioning.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change from baseline motricity index at 8 weeks and 3 months</measure>
    <time_frame>Pre (3x baseline) &amp; post intervention (8 weeks), 3 month follow-up</time_frame>
    <description>The Motricity Index (Ml) is a test that was originally constructed to clinically measure muscle strength in arm and legs of persons with neurological diseases.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline plate tapping tasks at 8 weeks and 3 months</measure>
    <time_frame>Pre (3x baseline) &amp; post intervention (8 weeks), 3 month follow-up</time_frame>
    <description>Plate tapping tasks consist of rapid continuous aiming movements to small and large targets.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline active Range of Motion at 8 weeks and 3 months</measure>
    <time_frame>Pre (3x baseline) &amp; post intervention (8 weeks), 3 month follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline perceived strength &amp; fatigue at 8 weeks and 3 months</measure>
    <time_frame>Pre (3x baseline) &amp; post intervention (8 weeks), 3 month follow-up</time_frame>
    <description>In order to gauge the participants' perceived strength and perceived fatigue, Visual Analogue Scales are used, on which answers to two simple questions (&quot;How strong do you feel regarding your arm muscles?&quot; and &quot;How fatigued do you feel at present?&quot;) are rated by the participant.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>change from baseline ABILHAND at 8 weeks and 3 months</measure>
    <time_frame>Pre (3x baseline) &amp; post intervention (8 weeks), 3 month follow-up</time_frame>
    <description>The ABILHAND is a clinical assessment tool evaluating perceived everyday performance of the impaired hand related to real life tasks using a set of 23 bimanual activities.</description>
  </other_outcome>
  <other_outcome>
    <measure>change from baseline Manual Ability Measure at 8 weeks and 3 months</measure>
    <time_frame>Pre (3x baseline) &amp; post intervention (8 weeks), 3 month follow-up</time_frame>
    <description>The Manual Ability Measure (MAM) is developed as a patient-reported outcome measure to complement other objective evaluations of functional limitations.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Multiple Sclerosis</condition>
  <condition>Paralytic Stroke</condition>
  <arm_group>
    <arm_group_label>MS &amp; chronic stroke patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: 8 weeks of I-TRAVLE based training of proximal arm function, using the haptic master.
Each week participants will attend training sessions on 5 days per 2 weeks, during which they will train 2 times 30 minutes I-TRAVLE assisted therapy, of which 1x 30 minutes supervised self-training. The two times half an hour training sessions per day will be interspaced by at least half an hour to avoid (general) fatigue and overuse of the affected arm in the subjects.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Haptic Master</intervention_name>
    <description>The Haptic Master (HM) is a haptic device controlled according to the principles of 'admittance control'. In admittance control 'force' applied to the system (i.e. the HM arm) is measured, while 'position' (of the HM arm) is the end result.</description>
    <arm_group_label>MS &amp; chronic stroke patients</arm_group_label>
    <other_name>MOOG, Nieuw Vennep</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinically diagnosed with a central paresis of the arm/hand at entry in the study,
             caused by a supratentorial stroke;

          -  Post-stroke time more than 6 months (i.e. chronic phase after stroke);

          -  Having completed their active clinical rehabilitation program

          -  Hemiparesis featuring a low to moderate proximal (shoulder and arm) muscle strength:

        Motricity Index shoulder/arm item: minimum score of 14 and maximum 25 (out of 33),
        corresponding to a maximum active shoulder abduction of up to 90 degrees without
        resistance; and/or a minimum active shoulder anteflexion of 30 degrees and a maximum active
        range of motion of 120 degrees shoulder joint anteflexion which can actively be maintained
        for 10 seconds;

          -  a fair cognitive level, i.e. being able to understand the questionnaires and
             measurement instructions;

          -  ability to read and understand Dutch.

        Exclusion Criteria:

          -  Severe spasticity of the arm, i.e. Modified Ashworth Scale (MAS) score for the elbow
             and wrist flexors: each â‰¥ 3;

          -  Severe visual impairment and/or severe cognitive impairment which may interfere with
             the execution of the arm-hand tasks or the measurements;

          -  Severe neglect in the near extra personal space (38), established by the letter
             cancellation test (39) and Bell's test (quantitative evaluation, (40)) with a minimum
             omission score of 15% (Ferber, 2001);

          -  Broca aphasia, Wernicke aphasia, global aphasia: as determined by the Akense Afasie
             Test (AAT) (41);

          -  Severe apraxia as measured by the apraxia test of van Heugten (42);

          -  no informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Feys, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hasselt</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Feys</last_name>
    <email>peter.feys@uhasselt.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anneleen Maris</last_name>
    <email>anneleen.maris@uhasselt.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Revalidatie &amp; MS Centrum Overpelt</name>
      <address>
        <city>Overpelt</city>
        <state>Limburg</state>
        <zip>3900</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veronique Truyens</last_name>
      <email>veronik.truyens@msreva.be</email>
    </contact>
    <contact_backup>
      <last_name>Mieke Lemmens</last_name>
      <email>mieke.lemmens@msreva.be</email>
    </contact_backup>
    <investigator>
      <last_name>Mieke Lemmens</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Adelante Zorggroep</name>
      <address>
        <city>Hoensbroek</city>
        <zip>6430 AB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henk Seelen</last_name>
      <email>H.Seelen@adelante-zorggroep.nl</email>
    </contact>
    <contact_backup>
      <last_name>Sandra Stupar</last_name>
      <email>s.stupar@adelante-zorggroep.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Sandra Stupar</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://i-travle.tumblr.com/</url>
    <description>Website on the Individualised Technology-supported Robot-assisted Learning Environment (I-TRAVLE) system</description>
  </link>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2013</study_first_submitted>
  <study_first_submitted_qc>August 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2013</study_first_posted>
  <last_update_submitted>August 6, 2013</last_update_submitted>
  <last_update_submitted_qc>August 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hasselt University</investigator_affiliation>
    <investigator_full_name>Anneleen Maris</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

